: Public   Class
	
	DEFINITION:<br/>Information needed for computing the sample size, including any detail not provided <br/>in the study protocol.<br/><br/>EXAMPLE(S):<br/>"Approximately 100 patients will be randomized to each of the 3 treatment groups. <br/>Previous experience with the oral formulation of xanomeline suggests that this <br/>sample size has 90% power to detect a 3.0 mean treatment difference in ADAS-Cog <br/>(p#lt;.05, two-sided), based on a standard deviation of 6.5. Furthermore, this sample <br/>size has 80% power to detect a 0.36 mean treatment difference in CIBIC+ (p#lt;.05, <br/>two-sided), based on a standard deviation of 0.9."<br/><br/>OTHER NAME(S):<br/><br/>NOTE(S):<br/>InterventionalStudyProtocolVersion.interventionGroupQuantity, <br/>Arm.targetAccrualNumberRange, and StudyProtocolVersion.targetAccrualNumberRange are <br/>all related to parts of the SampleSizeConsideration that are not yet fully modeled <br/>here.<br/>
	
		
			- Attributes
 
			- Associations To
 
			- Tagged Values
 
			- Other Links
 
		
	
		
			| Attribute | 
		
						
				
					Public ED   text
				 | 
			
			
														
					 Details:
					
					
						
							| Alias: | 
							 | 
						 
						
							| Initial: | 
							 | 
						 
						
							| Stereotype:  | 
							 | 
						 
						
							| Ordered:  | 
							 | 
						 
						
							| Range:  | 
							Range:0 to 1 | 
						 
						
							| Transient:  | 
							False | 
						 
						
							| Derived:  | 
							False | 
						 
							
							| IsID:  | 
						False | 
						 
					 
					
					Map:Statistics v1.0=SampleSizeConsideration.text 
						
	
		| 
			Notes:  
		 | 
		
			DEFINITION:<br/>A textual or media-based representation of the sample size consideration, including <br/>details needed to replicate sample size calculations.<br/><br/>EXAMPLE(S):<br/>"Approximately 100 patients will be randomized to each of the 3 treatment groups. <br/>Previous experience with the oral formulation of xanomeline suggests that this <br/>sample size has 90% power to detect a 3.0 mean treatment difference in ADAS-Cog <br/>(p#lt;.05, two-sided), based on a standard deviation of 6.5. Furthermore, this sample <br/>size has 80% power to detect a 0.36 mean treatment difference in CIBIC+ (p#lt;.05, <br/>two-sided), based on a standard deviation of 0.9."<br/><br/>OTHER NAME(S):<br/><br/>NOTE(S):<br/>Details included could be: difference to be detected, variability, assumptions.<br/>
		 | 
	 
  
						
				 | 
			
	
 
		
			
				
					| Element | 
					Source Role | 
					Target Role | 
				
				
					
						StatisticalAnalysisPlanVersion 
						Class  
					 | 
					
						Name: includedSampleSizeConsideration 
						 
					 | 
					
						Name: includingStatisticalAnalysisPlanVersion 
						 	
					 | 
				
				
					
						 Details:
							 
							DESCRIPTION:<br/>Each SampleSizeConsideration always is included in one StatisticalAnalysisPlanVersion. Each StatisticalAnalysisPlanVersion might include one or more SampleSizeConsideration.<br/><br/>DEFINITION:<br/>Identifies the considerations that inform the calculation of the sample size for a given version of a statistical analysis plan.<br/><br/>EXAMPLE(S):<br/><br/>OTHER NAME(S):<br/><br/>NOTE(S):<br/><br/> 
							 
						 
					 | 
				
			
		 
	
		
			| Tag | 
			Value | 
		
					
				| Map:Statistics v1.0 | 
				SampleSizeConsideration | 
			
	
			
				
					 Details:
						 
						 
						 
					 
				 | 
			
	
 		
			
				
					| Object | 
					Type | 
					Connection | 
					Direction | 
					Notes | 
				
				
					| StatisticalAnalysisPlanVersion | 
					Class | 
					Weak | 
					To | 
					DESCRIPTION:
Each SampleSizeConsideration always is included in one StatisticalAnalysisPlanVersion. Each StatisticalAnalysisPlanVersion might include one or more SampleSizeConsideration.
DEFINITION:
Identifies the considerations that inform the calculation of the sample size for a given version of a statistical analysis plan.
EXAMPLE(S):
OTHER NAME(S):
NOTE(S):
 |